Optiver Holding B.V. Tenaya Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 54 shares of TNYA stock, worth $78. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54Holding current value
$78% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
35.6MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$13.6 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$7.34 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.91 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$2.67 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.74MShares$2.53 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $60M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...